MAYNE Pharma has reported
stellar revenue and profit growth
for the first half full year (1HFY15)
ending 31 Dec, positioning the
company “to deliver continued
financial growth success across
FY16 driven by opportunities across
multiple channels and all business
segments.
The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 26 Feb 16
To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 26 Feb 16
